Literature DB >> 2849521

Evolution of angiotensin-converting enzyme inhibitors.

M J Wyvratt1.   

Abstract

The renin-angiotensin system is perhaps the most important hormonal system in the regulation of blood pressure. Its influence on blood pressure is mediated by the potent vasoconstrictor angiotensin II. Since angiotensin-converting enzyme performs the last step in the biosynthesis of angiotensin II, inhibition of this enzyme has attracted the attention of many researchers as a novel approach in the control of high blood pressure. The evolution of inhibitors of this enzyme will be traced from the early snake venom peptide inhibitors to the drugs currently available for the treatment of high blood pressure and congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849521

Source DB:  PubMed          Journal:  Clin Physiol Biochem        ISSN: 0252-1164


  2 in total

1.  Preparation of carboxylated magnetic particles for the efficient immobilization of C-terminally lysine-tagged Bacillus stearothermophilus aminopeptidase II.

Authors:  Cheng-Liang Huang; Wei-Chun Cheng; Jia-Ci Yang; Meng-Chun Chi; Jiau-Hua Chen; Hong-Ping Lin; Long-Liu Lin
Journal:  J Ind Microbiol Biotechnol       Date:  2010-04-07       Impact factor: 3.346

2.  Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

Authors:  D W Cushman; F L Wang; W C Fung; G J Grover; C M Harvey; R J Scalese; S L Mitch; J M DeForrest
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.